FDA product code GXC: Device, Electroconvulsive Therapy

GXC is the FDA product code for device, electroconvulsive therapy. It is a Class III device, regulated under 21 CFR 882.5940 and reviewed by the Neurology panel. Devices under GXC reach the market by PMA; FDA lists no cleared 510(k)s for it.

Classification

FieldValue
Device nameDevice, Electroconvulsive Therapy
Device classClass III
Regulation21 CFR 882.5940
Review panelNE — Neurology
Medical specialtyNeurology
Premarket routePMA

Recalls for GXC devices

FDA recall records list no recalls for product code GXC.

Frequently asked questions

What is FDA product code GXC?

GXC is the FDA product code for device, electroconvulsive therapy. It is a Class III device, regulated under 21 CFR 882.5940 and reviewed by the Neurology panel.

What device class is GXC?

Class III, regulation 21 CFR 882.5940. Typical premarket route: PMA.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Neurology product codes · FDA product code lookup · 510(k) database search · 510(k) review times